Anaplastic carcinoma of the pancreas with squamous features: Report of a case and immunohistochemical study

Medical Science Monitor

Volumn 11, Issue 11, 2005, Pages

  Sawai, Hirozumi ^a   Okada, Yuji ^a   Funahashi, Hitoshi ^a   Matsuo, Yoichi ^a   Takeyama, Hiromitsu ^a   Manabe, Tadao ^a  

^a NAGOYA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCES   (Japan)

Author keywords

Anaplastic carcinoma; Immunohistochemistry; Integrins; Interieukin 1 receptor type I; Pancreatic neoplasms

Indexed keywords

ALPHA6 INTEGRIN; CYCLINE; GEMCITABINE; INTERLEUKIN 1 RECEPTOR;

AGED; ANAPLASTIC CARCINOMA; ARTICLE; ASIAN; CANCER CHEMOTHERAPY; CANCER DIAGNOSIS; CARCINOMATOUS PERITONITIS; CASE REPORT; GERIATRIC PATIENT; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LIVER METASTASIS; MALE; MORTALITY; PANCREAS CARCINOMA; PANCREAS RESECTION; POSTOPERATIVE CARE; PROGNOSIS;

AGED; CARCINOMA; CARCINOMA, SQUAMOUS CELL; FATAL OUTCOME; HUMANS; IMMUNOHISTOCHEMISTRY; INTEGRINS; MALE; PANCREATIC NEOPLASMS; PERITONEAL NEOPLASMS; PROGNOSIS; RECEPTORS, INTERLEUKIN-1; TUMOR MARKERS, BIOLOGICAL;

EID: 28144449836     PISSN: 12341010     EISSN: 16433750     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Cubilla AL, Fitzgerald PJ: Morphological patterns of primary non-endocrine human pancreas carcinoma. Cancer Res, 1975; 35: 2234-48
2. Chen J, Baithun SI: Morphological study of 391 cases of exocrine pancreatic tumors with special references to the classification of exocrine pancreatic carcinoma. J Pathol, 1985; 146: 17-29
3. Tschang T-P, Garza-Garza R, Kissane JM: Pleomorphic carcinoma of the pancreas. An analysis of 15 cases. Cancer, 1977; 39: 2114-26
4. Morohoshi T, Held G, Klöppel G: Exocrine pancreatic tumors and their histological classification. A study based on 167 autopsy and 97 surgical cases. Histopathology, 1983; 7: 645-61
5. Wolfman NT, Karstaedt N, Kawamoto EH: Pleomorphic carcinoma of the pancreas: Computed-tomographic, sonographic, and pathologic findings. Radiology, 1985; 154: 329-32
6. Ozaki H, Hiraoka T, Mizumoto R et al: The prognostic significance of lymph node metastasis and intrapancreatic perineural invasion in pancreatic cancer after curative resection. Surg Today, 1999; 290: 16-22
7. Meyer W, Jurowich C, Reichel M et al: Pathomorphological and histological prognostic factors in curatively resected ductal adenocarcinoma of the pancreas. Surg Today, 2000; 30: 582-87
8. Chadha MK, LeVea C, Javle M et al: Anaplastic pancreatic carcinoma. A case report and review of literature. J Pancreas, 2004; 5: 512-15
9. Alguacil-Garcia A, Weiland LH: The histologic spectrum, prognosis, and histogenesis of the sarcomatoid carcinoma of the pancreas. Cancer, 1977; 39: 1181-89
10. 1 expression and metastatic capability of human pancreatic cancer. Oncology, 2003; 65: 167-73
11. Sawai H, Funahashi H, Matsuo Y et al: Expression and prognostic roles of integrins and interleukin-1 receptor type I in patients with ductal adenocarcinoma of the pancreas. Dig Dis Sci, 2003; 48: 1241-50
12. nd English ed. Tokyo, Kanehara, 2003
13. Chetty R, Clark SP, Pitson GA: Primary small cell carcinoma of the pancreas. Pathology, 1993; 25: 240-42
14. Cubilla AL, Fitzgerald PJ: Classification of pancreatic cancer (nonendocrine). Mayo Clin Proc, 1979; 54: 449-58
15. Roche J, Del Buono E, Domenico D, Colturi TJ: Anaplastic carcinoma arising in ectopic pancreas located in the distal esophagus. J Clin Gastroenterol, 1996; 22: 242-44
16. Kamisawa T, Iwasa T, Koike M et al: Hematogenous metastases of pancreatic ductal carcinoma. Pancreas, 1995; 11: 345-49
17. Kamisawa T, Tabata I, Isawa T et al: A case of pleomorphic carcinoma of the pancreas showing sequential histological change by immunohistochemical study. Int J Pancreatol, 1995; 18: 67-70
18. Connolly MM, Dawson PJ, Michelassi F et al: Survival in 1001 patients with carcinoma of the pancreas. Ann Surg, 1987; 206: 366-73
19. Kuroda N, Sawada T, Miyazaki E et al: Anaplastic carcinoma of the pancreas with rhabdoid features. Pathol Int, 2000; 50: 57-62
20. Yonemasu H, Takashima M, Nishiyama KI et al: Phenotypical characteristics of undifferentiated carcinoma of the pancreas: a comparison with pancreatic ductal adenocarcinoma and relevance of E-cadherin, alpha catenin and beta catenin expression. Oncol Rep, 2001; 8: 745-52
21. Brattstrom D, Bergqvist M, Wester K et al: Endothelial markers and circulating angiogenic factors and p53 may be potential markers for recurrence in surgically resected non-small cell lung cancer patients. Med Sci Monit, 2004; 10(9): BR331-BR338
22. Bozcuk H, Gumus A, Ozbilim G et al: Cluster analysis of p-glycoprotein, c-erb-B2 and P53 in relation to tumor histology strongly indicates prognosis in patients with operable non-small cell lung cancer. Med Sci Monit, 2005; 11(6): HY11-HY20
23. Uemura K, Hiyama E, Murakami Y et al: Comparative analysis of K-ras point mutation, telomerase activity, and p53 overexpression in pancreatic tumours. Oncol Rep, 2003; 10: 277-83
24. Paal E, Thompson LD, Frommelt RA et al: A clinicopathologic and immunohistochemical study of 35 anaplastic carcinomas of the pancreas with a review of the literature. Ann Diagn Pathol, 2001; 5: 129-40